Agoracom Blog Home

Posts Tagged ‘#smallcapstocks’

Lithium Canada 2016 Phase One Exploration Program Update Southeastern Manitoba $PFN.ca

Posted by AGORACOM-JC at 9:07 AM on Thursday, October 27th, 2016

Hublogo1_copy

-Phase One Program of Pegmatite Sampling Completed on Lithman North, Lithium One and Lithium Two.

-Assay Results currently pending from the lab

-Lithman East is currently being Explored

-Numerous Pegmatites have been Reviewed and Sampled in the field

-Objective of a Summer/Fall Program: to Complete both Geological Reports and Go Forward Recommendations, on each of the Company’s 5 Lithium Projects in Manitoba

Vancouver, BC / October 27, 2016 – Pacific North West Capital Corp. (“PFN”, the “Company”) (TSXV: PFN; FSE: P7J; OTCQB: PAWEF) announces that its 100% owned subsidiary, Lithium Canada Developments, has been conducting its Phase One Exploration Program, of Pegmatite Exploration, and Sampling, over the past several months in SE Manitoba. Phase One is Near Completion and Assay Results are pending from the laboratory.

The Company carried out a Surface Phase One Exploration Program in the latter part of the summer of and into the fall of 2016. The purpose of this program was to Examine and Sample the known Surface Pegmatites, for their Lithium and REE potential. To date, the Surface Programs on Lithman North, Lithium One and Lithium Two Projects have been Completed. The Lithman East Project is currently underway and should be completed by the end of October.

The Phase One Exploration Program, as planned, will lay the groundwork for Future Exploration Plans, the Completion of a Geological Report, having further recommendations, with the goal of defining Drill Programs on our Manitoba Li Projects. Historic records from the region have indicated the Presence of Lithium Minerals to be present in several of the Pegmatites. Sampling has been carried out to confirm Lithium values.

All projects are situated in the Cat Lake – Winnipeg River Pegmatite Field of SE Manitoba. This Pegmatite Field hosts the World Class Tanco Pegmatite, which has been mined from an underground operation at the Tanco Mine Site, in various capacities, since 1969. It used to be one of the primary producers of Spodumene (a primary Lithium ore) in North America.

Current NI43-101 compliant resource calculations are not available for the Tanco Pegmatite. Academic publications have estimated the size of the deposit to be up to approximately 57 million tonnes. The last non-compliant published mineral reserves from the Tanco Pegmatite (end of 1992) were 1.075 million tonnes of 0.12% Ta2O5, 3.5 million tonnes of 2.7% LiO2, and 315,000 tonnes of 23.3% Cs2O.


Click Image To View Full Size

Manitoba Lithium Projects Location Map

About the Company’s Lithium Division

The Company’s new Lithium Division will focus on the Discovery, Acquisition, Exploration and Development of Lithium Projects in Canada. In the United States, the Company will use its wholly owned U.S.A subsidiary, to Acquire and Develop Projects in Active Mining Camps in Nevada, Arizona and California.

Management believes that these New Age Metals, Lithium, Platinum Group Metals (PGM’s) and Rare Earths, have robust macro trends with Surging Demands and Limited Supply. Going forward, this New Division will Explore for the minerals needed to fuel the demand for Energy Storage and other Core 21st Century Technologies.

The Company has a growing portfolio of Lithium Projects. The Clayton Valley Forks Li Project in Nevada is a recent Lithium Brine Project Acquired by the Company (PFN News Releases April 25th, 2016 and May 9th, 2016). The Company also has 5 Hard Rock Lithium projects in Canada (PFN News Releases April 21st, 2016; May 24th, 2016; June 15th, 2016; July 5th, 2016 and August 16th, 2016), located in the Cat Lake – Winnipeg River Pegmatite Field of SE Manitoba.

Lithium and Platinum Group Metal Prices Have Improved Dramatically in recent months. Lithium Supplies remain in deficit, relative to their demand. Both Metals Groups are used for the expanding worldwide automobile industry (conventional and electric). In the case of PGMs, demand is increasing for Autocatalysts, a key component for reducing toxic emissions for automotive, gasoline and diesel engines. Regarding Lithium, there is an ever-increasing demand for batteries in cellphones, laptops, electric cars, solar storage, wireless charging and renewable energy products.

An aggressive 2016/17 Acquisition and Exploration Program is underway, with the objective of having several projects at the Drill Ready stage, by early 2017.

About the Company’s Platinum Group Metals Division

Achievements to date and future plans for River Valley are outlined below as follows:

  1. 1.PFN currently has 100% ownership in the River Valley Project, subject to a 3% NSR, with Options to buy down;
  2. 2.Completed Exploration and Development Programs on the River Valley Property include more than 600 holes drilled since year 2000 and several mineral resource estimates and metallurgical studies;
  3. 3.Results for the current (2012) mineral resource estimate are below;
  4. 4.2015 Drill Program confirms New High Grade T2 Discovery


Click Image To View Full Size

  1. 5.Exploration and Development Plans outlined for 2016
  2. 6.Ongoing Strategic Partner search for River Valley Project
  3. 7.Results for the most recent Metallurgical Testwork Study are summarized below:

– Prepared by Tetra Tech (Wardrop)

– High Confidence: Measured plus Indicated = 72% of total

– Reported on PdEq basis: Pd=40% & Pt=20% of the payable metals

– Pd to Pt ratio = 2.5:1; Cu to Ni ratio = 3:1

– High Grade potential, particularly in the north part of River Valley deposit

– Resources under evaluation for development potential as open pit mining operation


Click Image To View Full Size


Click Image To View Full Size

  1. 8.Results for the 2015 Discovery Drill Program on the T2 Target are as follows:

– Drill hole intercepts much higher than average grade, of current mineral resource estimate

– Possible new mineralized zone, at the north end of the River Valley Deposit

– Recent results show potential to take the River Valley PGM Project in a new direction

-More drilling required and field crews have Completed Ground-Proofing Targets, to better plan Fall and Winter Drill Programs


Click Image To View Full Size

  1. 9. Exploration and Development Plans for 2016:

-Mineral Prospecting and Geological Mapping on surface

-Drill Programs Targeted to add more, higher grade – Fall Drill Program, on the T2 Discovery, Underway

-Geological Interpretation and 2D/3D Modeling of all Drill and Surface results

-Application to the OPA’s Junior Exploration Assistance Program (JEAP) for 33% refund

of all Exploration Expenditures, up to $300,000.

-Ongoing Strategic Partner Search for River Valley

  1. 10.PFN has recently (News Release August 4th, 2016) acquired additional ground in the River Valley area from Mustang Minerals
  2. 11.Aggressive on-going Project Acquisition Program in North America, with Specific focus on the Sudbury Mining District and in Alaska

QUALIFIED PERSON

The contents contained herein, which relate to Exploration Results or Mineral Resources, is based on information compiled, reviewed or prepared by Dr. Bill Stone, Principal Consulting Geoscientist, for Pacific North West Capital. Dr. Stone is a Qualified Person, as defined by National Instrument 43-101 and has reviewed and approved the technical content.

On behalf of the Board of Directors

” Harry Barr ”

Harry Barr

Chairman and CEO

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Note Regarding Forward Looking Statements: This release contains forward-looking statements that involve risks and uncertainties. These statements may differ materially from actual future events or results and are based on current expectations or beliefs. For this purpose, statements of historical fact may be deemed to be forward-looking statements. In addition, forward-looking statements include statements in which the Company uses words such as “continue”, “efforts”, “expect”, “believe”, “anticipate”, “confident”, “intend”, “strategy”, “plan”, “will”, “estimate”, “project”, “goal”, “target”, “prospects”, “optimistic” or similar expressions. These statements by their nature involve risks and uncertainties, and actual results may differ materially depending on a variety of important factors, including, among others, the Company’s ability and continuation of efforts to timely and completely make available adequate current public information, additional or different regulatory and legal requirements and restrictions that may be imposed, and other factors as may be discussed in the documents filed by the Company on SEDAR (www.sedar.com), including the most recent reports that identify important risk factors that could cause actual results to differ from those contained in the forward-looking statements. The Company does not undertake any obligation to review or confirm analysts’ expectations or estimates or to release publicly any revisions to any forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. Investors should not place undue reliance on forward-looking statements.

Tetra Bio-Pharma Announces Acquisition of Intellectual Property for the Development of Natural Health Products Through Its Agro-Tek Subsidiary $TBP.ca

Posted by AGORACOM-JC at 8:35 AM on Wednesday, October 26th, 2016

Tbp_large

  • Announced that it has acquired multiple intellectual property assets related to the initiation of manufacturing and distribution of products for natural health care including products containing extracts or oils derived from Cannabis sativa
  • Recently announced awarding of the NSERC Engage partnership grant with McGill University will allow AGTK to achieve its commercial strategy to launch Cannabis-derived supplements that comply with the existing regulations regarding cannabis and cannabinoid content

OTTAWA, ONTARIO–(Oct. 26, 2016) – Tetra Bio-Pharma Inc. (“Tetra Bio” or the “Company“) (CSE:TBP)(CSE:TBP.CN), through its subsidiary, Agro-Tek Inc. (“AGTK“), is pleased to announce that it has acquired multiple intellectual property assets related to the initiation of manufacturing and distribution of products for natural health care including products containing extracts or oils derived from Cannabis sativa.

The recently announced awarding of the NSERC Engage partnership grant with McGill University will allow AGTK to achieve its commercial strategy to launch Cannabis-derived supplements that comply with the existing regulations regarding cannabis and cannabinoid content. According to the United States Food and Drug Administration (“FDA“), “FDA is not aware of any evidence that would call into question its current conclusion that cannabidiol products are excluded from the dietary supplement definition under section 201(f)(3)(B)(ii) of the Federal Food, Drug, & Cosmetics Act.”

Mr. André Rancourt, the Company’s CEO commented, “CBD or THC containing dietary supplements are currently not allowed on the USA market. However, the goal of the McGill University partnership is the development of extracts of the plant Cannabis sativa, including THC and CBD-free for the development of dietary supplements.” AGTK intends on manufacturing and commercializing supplements, food-type products and, natural health products that are compliant with Canadian and USA federal regulations. Mr. Rancourt added, “This commercial strategy involves the expertise of two of the Company’s subsidiaries, AGTK and MMP, and is in line with the Company’s vision to make AGTK and MMP leaders in the development of Cannabis sativa, derived products for the consumer market, and for the commercialization of natural supplements derived from Cannabis sativa.”

The assets acquired include proprietary formulations that have obtained marketing approval from Health Canada. The line consists of:

1. Glucose Aid; NPN 80058089

2. Kava Kava; NPN 80061986

3. Stress Ado; NPN 80065911

4. Toux Ado (Cough Ado); NPN 80065923

5. Toux enfant (Cough Children); NPN 80065928

6. Water Relax; NPN 80065948 (beverage supplement)

7. Water Cough; NPN 80066086 (beverage supplement)

8. Sleep Pro; NPN 80066679

9. Instant Relief; NPN 80066682 (topical gel for local pain relief).

The acquisition of these formulations and their proprietary ingredients will provide PhytoPain Pharma Inc. with an inventory of compounds and elements that will be used as secondary ingredients or catalysts in the formulation of our pharmaceutical grade products.

In consideration for the acquisition of the assets, the Company has issued 1,800,000 common shares to arms’ length individuals. The shares issued will be subject to a four-month hold period.

According to Mr. Rancourt, these products will allow AGTK to begin generating revenues. This is the first set of products for AGTK’s portfolio. The company will be seeking to acquire additional product lines for distribution in North America. AGTK is engaged in negotiations to acquire national distributors to expand brand identity and facilitate distribution across North America

The Canadian Securities Exchange (CSE) has not reviewed this news release and does not accept responsibility for its adequacy or accuracy.

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, through its wholly-owned subsidiary, GrowPros MMP Inc., to obtain a licence for the production of medical marijuana; failure to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Tetra Bio-Pharma Inc.
Andre Rancourt
Chief Executive Officer

Ryan Brown
VP Business Development and Communications

Andre Audet
Executive Chairman
(613) 421-8402
[email protected]

Durango Provides Visits Limestone Projects Near Potential Petronas LNG Project $DGO.ca

Posted by AGORACOM-JC at 9:23 AM on Tuesday, October 25th, 2016

Logo

  • Exploration team is now in northern British Columbia at its Smith Island and Mayner’s Fortune limestone projects
  • Currently holds the past producing Smith Island limestone project located 6km southwest of Lelu Island which is where Petronas’ $36B proposed LNG facility is expected to be built

Vancouver, BC / October 25, 2016 – Durango Resources Inc. (TSX.V-DGO), (the “Company” or “Durango”) announces that further to its news of October 17th, 2016, the exploration team is now in northern British Columbia at its Smith Island and Mayner’s Fortune limestone projects.

Durango currently holds the past producing Smith Island limestone project located 6km southwest of Lelu Island which is where Petronas’ $36B proposed LNG facility is expected to be built. Durango also holds a 320-hectare property called the Mayner’s Fortune located 7.5km southwest of Terrace, B.C. which hosts six mapped sub parallel limestone units.

The Company is conducting its first phase exploration program on its limestone properties which is expected to include sampling to test for limestone quality, and mapping to confirm the historical reports. The Company is also investigating British Columbia minfile #103H 073 in the region for limestone potential. Further updates will be provided as they become available.

About Durango

Durango is a natural resources company engaged in the acquisition and exploration of mineral properties. The Company has a 100% interest in the Mayner’s Fortune and Smith Island limestone properties in northwest British Columbia, the Decouverte and Trove gold properties in the Abitibi Region of Quebec, and certain lithium properties near the Whabouchi project, the Buckshot graphite property near the Miller Mine in Quebec, the Dianna Lake silver project in northern Saskatchewan, the Whitney Northwest property near the Lake Shore Gold and Goldcorp joint venture in Ontario, as well as three sets of claims in the Labrador nickel corridor.

For further information on Durango, please refer to its SEDAR profile at www.sedar.com.

Marcy Kiesman, Chief Executive Officer

Telephone: 604.428.2900 or 604.339.2243

Facsimile: 888.266.3983

Email: [email protected]

Website: www.durangoresourcesinc.com

Forward-Looking Statements

This document may contain or refer to forward-looking information based on current expectations, including commencement and completion of future exploration, final approval from governmental entities on the LNG project, Petronas determining whether to proceed with the LNG project and the impact on the Company of these events. Forward-looking information is subject to significant risks and uncertainties, including market conditions, as actual results may differ materially from forecasted results. Forward-looking information is provided as of the date hereof and we assume no responsibility to update or revise them to reflect new events or circumstances. For a detailed list of risks and uncertainties relating to Durango, please refer to its prospectus filed on its SEDAR profile at www.sedar.com.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Tetra Bio-Pharma Inc. Is Increasing Its $750,000 Non-Brokered Private Placement $TBP.ca

Posted by AGORACOM-JC at 4:33 PM on Monday, October 24th, 2016

Tbp_large

  • Increasing its $750,000 non-brokered private placement (ref.: news release of October 20, 2016) to $1,000,000 for up to 6,666,667 units at a price of $0.15 per unit
  • Each unit will be consisting of one common share and one non-transferable warrant, with a whole warrant entitling the holder to purchase one common share at a price of $0.20 for a period of 12 months following the closing date

OTTAWA, ONTARIO–(Oct. 24, 2016) – Tetra Bio-Pharma Inc. (“Tetra Bio” or “the Company”) (CSE:TBP)(CSE:TBP.UN) is increasing its $750,000 non-brokered private placement (ref.: news release of October 20, 2016) to $1,000,000 for up to 6,666,667 units at a price of $0.15 per unit. Each unit will be consisting of one common share and one non-transferable warrant, with a whole warrant entitling the holder to purchase one common share at a price of $0.20 for a period of 12 months following the closing date.

The private placement is expected to close no later than November 30, 2016.

The securities issued pursuant to the private placement will be subject to a four-month hold period from the closing date. The Company may pay a commission in connection with the private placement, subject to compliance with the policies of the Exchange. Completion of the private placement and the payment of any commissions remain subject to the receipt of all necessary regulatory approvals, including the approval of the Exchange.

The proceeds of the private placement will be used to initiate clinical trials.

The Canadian Securities Exchange (CSE) has not reviewed this news release and does not accept responsibility for its adequacy or accuracy.

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, through its wholly-owned subsidiary, GrowPros MMP Inc., to obtain a licence for the production of medical marijuana; failure to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Andre Rancourt
Chief Executive Officer

Ryan Brown
VP Business Development and Communications

André Audet
Executive Chairman
[email protected]
(613) 421-8402

WEEKEND FEATURE: PFN (PFN:TSXV) At the Forefront of PGM and Lithium Exploration $PFN.ca

Posted by AGORACOM-JC at 4:50 PM on Friday, October 21st, 2016

Hublogo1_copy

PACIFIC NORTH WEST CAPITAL CORP.

(PFN:TSXV)

Two Divisions: PGM and Lithium

Pacific North West Capital belongs to the International Metals Group. Here are our other great companies.

  • PGM Division: focus on Development of the 100% owned River Valley PGM Project. Canada’s Largest Undeveloped Primary PGM Resource, with 2.5 Moz PGM, in Measured plus Indicated mineral resources. New Discovery in 2015. Summer Surface Exploration ongoing and a Fall 2016 drill program to follow-up.
  • Lithium Canada: formed April 2016, with a focus on Exploration of Hard Rock Lithium, in Manitoba, Canada and Lithium Brine in Nevada. The company uses the Prospector Generator Model.

The company recently completed 2/3 of its C$1.5 million placement in June 2016 and is currently placing approximately C$500,000 at C5.5 cents with a full two year warrant at C10 cents for the first year and C20 cents for the second year

River Valley PGM Project

Largest Undeveloped Primary PGM Deposit in Canada

River Valley PGM Project is located 100 km east of Sudbury, Ontario

  • Sudbury hosts 1 of the Top 4 Nickel, Copper & PGM Mining & Processing Facilities , in the World
  • Skilled Workforce, Established Mining Culture; Safe, Stable Pro-Mining Jurisdiction
  • Excellent Road Access to River Valley Property; Rail and Power Nearby
  • $30M Invested in Exploration, Large High-Confidence Resource, Favourable Metallurgy
  • High Grade Drill Hole Discovery March 2015

Mineral Resources – Project has had Five, 43-101 Reports

  • May 2012 Measured Resources: 26 Mt @ 1.4 g/t Palladium equivalent at cut-off grade ≥0.8 g/t Palladium equivalent for 0.7 Moz PGM plus Gold.
  • May 2012 Indicated Resources: 66 Mt @ 1.4 g/t Palladium equivalent at cut-off grade ≥0.8 g/t Palladium equivalent for 1.7 Moz PGM plus Gold.
  • May 2012 Measured + Indicated Resources: 91 Mt @ 1.4 g/t Palladium equivalent at cut-off grade ≥0.8 g/t Palladium equivalent for 2.4 Moz PGM plus Gold
  • May 2012 Inferred Resources: 36 Mt @ 1.1 g/t Palladium equivalent at cut-off grade of 0.8 g/t Palladium equivalent for 0.6 Moz PGM plus Gold
  • (see www.PFNCapital.com for Details and Notes on the Resource Estimate)
  • Mineral Resources covered by Mining Leases (21-year Renewable Term)
  • Concentrate Grades: 16% Cu, 189 gpt PGM; Recoveries: 84% Cu, 69% PGM;
  • No Deleterious Metals or Minerals

Watch Our Recent Interview

Hub On AGORACOM / Corporate Profile

FEATURE: Explor Resources (EXS: TSX-V) 609K oz Indicated / 470K oz Inferred Gold $EXS.ca

Posted by AGORACOM-JC at 9:41 AM on Friday, October 21st, 2016

Why Explor Resources?

  • Flagship Property Offers The Following:
  • NI 43-101 Resource – 609,000 oz Indicated / 470,000 Inferred
  • Teck Resources To Spend $12 MILLION To Earn 70%
  • Property Is 13 KM From Downtown Timmins
  • 2nd Project 43-101 Open Pit Resource
  • 1.4 MILLION T Indicated @ 1.38% Copper
  • 2.09 MILLION T Inferred @ 1.26% Copper

ONTARIO AND NEW BRUNSWICK PROPERTIES CURRENTLY UNDER EXPLORATION

Timmins Porcupine West (TPW) (4300 ha)

  • NI 43-101 Resource: 609,000 oz Indicated
    470,000 oz Inferred Gold
  • 13 km from downtown Timmins
  • Property is 2.5 km, NE of LSG West Timmins Mine
  • Model: Hollinger McIntyre Gold System: 30,000,000 oz. Au
  • Discovery Hole 10-30 : 9.22g/tonne over 11.0 meters
  • Optioned to Teck Resources
  • Teck to spend $12,000,000 to earn 70% interest

Chester Copper & VMS Project (3500ha)

  • Mineral Target: Cu, Pb, Zn, Ag, & Au
  • 70 km SW of Bathurst NB
  • Structural Model Complete
  • 300 m wide x 2000m long mineralized Corridor identified
  • Ramp to ore zone (480 meter long (3m x 4m)
  • Optioned to Brunswick Resources (BRU)
  • Brunswick to spend $500,000 over 3 years
  • Explore to receive $40,000 and 5,000,000 shares of BRU
  • Open pit resource – NI 43-101 Resource: 1,400,000 Indicated t @ 1.38% Cu
    2,089,000 Inferred t @ 1.26 % Cu
  • Announced the start of a 2,000 meters diamond Drill program


Kidd Creek Project (2466 ha)

  • Mineral Target: Cu-Zn Ore
  • Located 1.0 km west of Kidd Creek Mine
  • Kidd Mine yielded 130M tonnes of Cu-Zn Ore since 1960
  • Numerous Geophysical max/min and IP Targets
  • So encouraged by the initial results of the 3000 meter program, decided to more than double the diamond drilling program planned to 7275.7 meters

QUEBEC PROPERTIES CURRENTLY UNDER EXPLORATION

East Bay (3203 ha):

  • Mineral Target: Gold
  • Lies on Porcupine Destor Fault Zone, on strike with Beattie & Donchester mine
  • Historical channel samples by Lacana Mining in 1982 including: 0.81 oz/ton over 5ft; 0.16 oz/ton over 6 ft; 0.10 oz/ton over 10 ft
  • Wrap around Clifton Star

Nelligan (1198 ha):

  • Mineral Target: Nickel
  • Located in Val d’Or mining district of Quebec
  • Historical grab samples of 10% Ni and 0.6% Cu obtained by INCO
  • Discovered anomalous Nickel, Copper Zones

Launay (2250 ha):

  • Mineral Target: Nickel
  • Mineralized zones contained in mafic volcanic rocks
  • Contiguous to Royal Nickel’s Dumont property (NW end)

12 Month Stock Chart

FEATURE: Wagering on eSports is projected to hit $23 BILLION by 2020 $GMBL

Posted by AGORACOM-JC at 11:33 AM on Thursday, October 20th, 2016

Vgabmlinglarge_copy
Online Wagering Platform for the Future of Competitive Gaming

Why VGambling Inc?

“There is no other way to say it … VGambling represents one of the best potential mega winners I’ve seen in years.” George Tsiolis, AGORACOM Founder

“The Business of eSports Is Set To Explode…. Billions of dollars will soon be wagered on eSports competitions. Brands, consultants and investors are always looking for the next great opportunity and eSports appears to be an able applicant for the role.” Forbes Magazine, October 15, 2015

The 5 Things You Need To Know:

1. eSports – Over 130 million people from around the world tune in to watch teams of video game players compete with each other.

2. eSports Wagering – Wagering on eSports is projected to hit $23 BILLION by 2020.

3. VGambling is the next generation online gambling company that is built for the purpose of facilitating as much of this wagering as possible

4. VGambling is fully licensed, compliant and authorized to legally transact in eSports wagering.

5. VGambling has assembled a team of officers and board members with significant star power in the world of eSports and online gambling

VIDEO: eSports Investing AGORACOM at League of Legends Finals

Who is VGambling Inc.?

  • Company intends to offer users from around the world the ability to wager on professional e-Sports events for real money in licensed and secure environment.
  • Makes it possible to play in multi-player video game amateur tournaments and win cash prizes.
  • Issued an Internet gambling License by the Kahnawake Gaming Commission in Canada
  • Applied for a License in Antigua and Barbuda.
  • Company intends to conduct real money interactive gaming activities on a global basis from our base in St. John’s, Antigua.
  • Bringing users from these two huge industries together by offering our users from around the world the opportunity to play, and bet on online single and multi-player, video game tournaments for real money in our secure and licensed environment.
  • Utilizing VGambling Inc.’s peer-to-peer wagering system, video game fans and enthusiasts everywhere will be able to place all manner of bets on eSports professional players’ performance. Wagering will be available on a wide range of professional eSports events from around the world.
  • Company also intends to offer the widest selection of video games of skill, designed to be compatible for all applications including mobile and in multiple languages, to be played online for real money in small groups, tournaments and major events

The Opportunity

INTERNET GAMBLING EXPENDITURE IS INCREASING GLOBALLY

Online gambling, also known as Internet gambling and iGambling, is a general term for gambling using the Internet.

  • $40B industry with +20% annual growth
  • Sports betting estimated to be 41% of total online market.
  • Internet gambling represents +10% of global gambling market

eSports

Electronic sports (also known as eSports, e-sports,
competitive gaming, or progamming in Korea) is a term for organized multiplayer video game competitions.
Last year Riot Games’ “League of Legends” world championship had 27 million streaming views. To provide some correlation, it was more than the average viewership of the World Series of baseball, which is the second most viewed sport in the USA. The number of professional eSports tournaments worldwide more than tripled from 430 in 2013 to 1,485 in 2014.

  • eSports organizations hosting major tournaments include the Electronic Sports League in Europe, Major League Gaming in North America, and the Korean eSports Association founded by the Korean government and affliated to the Korean Olympic Committee
  • China and Korea continue to dominate the global eSports market
  • eSports are currently being seriously considered by the IOC as an Olympic sport

Tetra Bio-Pharma Inc. Announces a $750,000 Non-Brokered Private Placement & Granting of Options $TBP.ca

Posted by AGORACOM-JC at 8:37 AM on Thursday, October 20th, 2016

Tbp_large

  • Non-brokered private placement of up to 5,000,000 units at a price of $0.15 per unit for aggregate gross proceeds of up to $750,000
  • Each unit will consist of one common share and one non-transferable warrant, with a whole warrant entitling the holder to purchase one common share at a price of $0.20 for a period of 12 months following the closing date.

OTTAWA, ONTARIO–(Oct. 20, 2016) – Tetra Bio-Pharma Inc. (“Tetra Bio” or “the Company”) (CSE:TBP)(CSE:TBP.CN) is conducting a non-brokered private placement of up to 5,000,000 units at a price of $0.15 per unit for aggregate gross proceeds of up to $750,000. Each unit will consist of one common share and one non-transferable warrant, with a whole warrant entitling the holder to purchase one common share at a price of $0.20 for a period of 12 months following the closing date.

The private placement is expected to close no later than November 30, 2016.

The securities issued pursuant to the private placement will be subject to a four-month hold period from the closing date. The Company may pay a commission in connection with the private placement, subject to compliance with the policies of the Exchange. Completion of the private placement and the payment of any commissions remain subject to the receipt of all necessary regulatory approvals, including the approval of the Exchange.

The proceeds of the private placement will be used to initiate clinical trials.

In other News:

The Company has received $341,783 in exercised warrants from September to October 2016.

The Company also announces that in accordance with the Company’s stock option plan and subject to the approval of the Canadian Securities Exchange, the Board of Directors granted an aggregate of 800,000 incentive stock options (“options”) to directors of the Company. Each option, vesting immediately upon grant, entitles the holder thereof to purchase one common share in the capital of the Company at a price of $0.18 per share until October 19, 2021. The options and any common shares issued upon exercise thereof will be subject to a four month resale restriction from the date of grant.

The Canadian Securities Exchange (CSE) has not reviewed this news release and does not accept responsibility for its adequacy or accuracy.

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, through its wholly-owned subsidiary, GrowPros MMP Inc., to obtain a licence for the production of medical marijuana; failure to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Tetra Bio-Pharma Inc.
Andre Rancourt
Chief Executive Officer
(613) 421-8402

Tetra Bio-Pharma Inc.
Ryan Brown
VP Business Development and Communications
(613) 421-8402

Tetra Bio-Pharma Inc.
Andre Audet
Executive Chairman
(613) 421-8402
[email protected]

Tetra Bio-Pharma Announces Awarding of NSERC Engage Grant Partnership to Grow Pros MMP and McGill University $TBP.ca

Posted by AGORACOM-JC at 8:31 AM on Wednesday, October 19th, 2016

Tbp_large

  • Announce that the National Sciences and Engineering Research Council of Canada (NSERC) has awarded an NSERC Engage Grant partnership to MMP and Dr. Stan Kubow of McGill University
  • As part of MMP’s mission to diversify and offer new products to consumers, with the award of the NSERC Engage partnership grant, MMP will establish a first research collaboration with McGill University and plans to invest in this program both financially and with in-kind contributions

OTTAWA, ONTARIO–(Oct. 19, 2016) – Grow Pros MMP Inc. (MMP), a subsidiary of Tetra Bio-Pharma Inc. (“TetraBio” or the “Company” or “TBP“) (CSE:TBP) is pleased to announce that the National Sciences and Engineering Research Council of Canada (NSERC) has awarded an NSERC Engage Grant partnership to MMP and Dr. Stan Kubow of McGill University.

As part of MMP’s mission to diversify and offer new products to consumers, with the award of the NSERC Engage partnership grant, MMP will establish a first research collaboration with McGill University and plans to invest in this program both financially and with in-kind contributions to pursue its research and development objectives and become a world leader in the development and commercialization of Cannabis-based products.

“The partnership with McGill University is in line with MMP’s vision to expand commercial operations and prepare to launch Cannabis sativa-derived supplement/retail or drug products for the North American market. This project will allow the development of intellectual property to protect future products that would be commercialized by TBP,” commented Ryan Brown.

“The proposed collaboration between Dr S. Kubow, Associate Professor, McGill University, relates to MMP’s need to develop an extraction process and to develop products using specific fractions of the plant Cannabis sativa. Fractions with the highest dermal and oral absorption will subsequently be characterized to further understand the pharmacology of these extracts,” commented Dr. Randy Ringuette, Ph.D. Medical Researcher, MMP Inc.

Dr. Stan Kubow stated, “We are excited by the collaboration with MMP that will allow us to utilize systematic state-of-the-art research methodologies to identify bioactives from Cannabis sativa for the development of science-based consumer products.”

According to Mr. A. Rancourt CEO of TBP, “We are very pleased by the decision of NSERC to award this partnership grant. This has implications for both MMP and AgroTek.” He added, “This is in line with TBP’s vision to make MMP a leader in the development of Cannabis sativa derived products for the consumer market and for the commercialization of natural supplements derived from Cannabis sativa by AgroTek.”

About Dr. Stan Kubow

Dr. S. Kubow, Ph.D. is an Associate Professor at the School of Dietetics and Human Nutrition, McGill University. His research interests include the impact of nutritional interventions on a variety of disease outcomes and metabolic disorders using technologically modified food extracts and isolates with enhanced bioactivity including phytochemical extracts, whey and soy proteins and probiotics. These studies have been focused upon oxidative stress, inflammatory indices, lipoprotein, fatty acid and glucose metabolism as related to cell signaling pathways and disease pathogenesis.

The Canadian Securities Exchange (CSE) has not reviewed this news release and does not accept responsibility for its adequacy or accuracy.

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, through its wholly-owned subsidiary, GrowPros MMP Inc., to obtain a licence for the production of medical marijuana; failure to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Tetra Bio-Pharma Inc.
Ryan Brown
VP Business Development and Communications

Tetra Bio-Pharma Inc.
Andre Rancourt
Chief Executive Officer
(613) 421-8402
[email protected]

Nevada Energy capitalizing on what Goldman Sachs calls the new gasoline in the electric vehicle revolution – lithium $BFF.ca

Posted by AGORACOM-JC at 9:32 AM on Tuesday, October 18th, 2016
Closeup of an electric car plug while recharging. High quality 3D rendering.Similar images:
  • Works aggressively toward the acquisition of new lithium targets in Nevada, one of the most mining friendly jurisdictions in the world and figuratively in the shadows of Tesla’s Gigafactory
  • Lithium has become a permanent topographic feature of the Nevada economic landscape
  • By 2018, the Gigafactory will reach full capacity and produce more lithium ion batteries annually than were produced worldwide in 2013

Nevada Energy Metals Inc. (TSXV: BFF | OTCQB: SSMLF | Frankfurt: A2AFBV) is capitalizing on lithium, what Goldman Sachs calls the new gasoline as an enabling commodity in the electric vehicle revolution. It is approaching the market smartly to minimize risk, keep overhead low and maximize shareholder value.

Nevada Energy is an exploration company focused on the acquisition and exploration of brine lithium projects in the world-class mining jurisdiction of Nevada. But Nevada Energy found its own way to minimize risk and leverage others money to capitalize on brine to supply the expanding lithium demand.

Nevada Energy works aggressively toward the acquisition of new lithium targets in Nevada, one of the most mining friendly jurisdictions in the world and figuratively in the shadows of Tesla’s Gigafactory.

Lithium has become a permanent topographic feature of the Nevada economic landscape. Tesla broke ground on the Gigafactory in June 2014 outside Sparks, Nevada, and we expect to begin battery cell production by the end of this year. By 2018, the Gigafactory will reach full capacity and produce more lithium ion batteries annually than were produced worldwide in 2013.

To service this market Nevada Energy has acquired mineral rights to 7 properties in Nevada,

  1. A 100% option-outagreement, 3% net-smelter royalty of the Dixie Valley Project (348 of 910 total claims covering 7,363 hectares/28.4 square miles) to LiCo Energy Metals (LIC.TSXV), covering the majority of the Humboldt Salt Marsh playa in Churchill County, Nevada;
  2. Acquisitionof 100% of the Big Smokey Valley Project (160 placer claims covering 3,200 acres/1,295 hectares) located in Nye County, Nevada;
  3. Acquisitionof 100% ownership in the Black Rock Desert Project (128 claims covering 2,560 acres/1,036 hectares) located in southwest Black Rock Desert, Washoe County, Nevada;
  4. A 70/30farm-out option JVto American Lithium Corp (LI.TSXV) on 77 claims in Clayton Valley, approximately 250m from the Rockwood Lithium mine, the only brine based lithium producer in North America;
  5. Acquisition of 100% in the Teels Marsh West project (100 claims covering 2000 acres/809 hectares) in Mineral County, Nevada;
  6. Acquisition of 100% ownership in the San Emidio Project (155 claims, 3,100 acres/1,255 hectares) near Empire, Washoe County, Nevada;
  7. Acquisition of the Alkali lake Project, 60% Option from Dajin Resources Corp. (191 claims covering 3,820 acres/1,558 hectares) in the Esmeralda County, Nevada.

Nevada Energy uses three time-tested approaches to maximize shareholder value:

  1. It teams up with other companies for exploration and development. This permits Nevada Energy to leverage its funds;
  2. It has formed an advisory board to streamline the selection, management and development of its lithium projects; and,
  3. It keeps overhead low even as it is well capitalized.

Incidentally, Goldman Sachs is both right and wrong about lithium being the next gasoline: the properties of lithium make it the best possible atoms for energy storage. Lithium is the lightest solid element on earth with double the energy density of the next closest alternative; it is also one of the most abundant elements on earth. These unique properties ideally position it for portable energy storage applications that will be a key enabler of the electric car revolution and replace gasoline as the primary source of transportation fuel.

Gasoline is a source of energy. But lithium is not and will never be until such time as we change the physical laws of the universe, which is safe to assume won’t happen during the four-year term of the next president of the United States.

Lithium is an atom that has the ability to store energy. It stores joules from solar, fossil, hydroelectric sources or nuclear. In reality Nevada Energy aims to provide the fuel tank to electric vehicles.

Source: http://investorintel.com/cleantech-intel/nevada-energy-corp-smart-moves-to-provide-gas-tank-to-electric-vehicles/